Study on the Regulatory Mechanism of GLP-1 Receptor Agonist Liraglutide in Diabetic Corneal Epithelial Wound Healing
Xin Liu, Hui Lin, Yuting Shao, Jiaqi Shen, Yanlong Bi · 2026
Read Study on the Regulatory Mechanism of GLP-1 Receptor Agonist Liraglutide in Diabetic Corneal Epithelial Wound Healing by Xin Liu, Hui Lin, Yuting Shao, Jiaqi Shen, Yanlong Bi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13641211.txt.
Description
Xin Liu and four co-authors tested a diabetes drug for healing wounds on the surface of the eye, in a study from twenty twenty-six. Diabetes can slow healing of the cornea, the clear front layer of the eye. The drug, liraglutide, is known for blood sugar control, and the team wanted to learn how it might help eye wounds close.
In diabetic mice and in cells grown under high sugar, the drug raised cell survival, growth, and movement, and cut cell death. It eased chemical stress inside cells through two known pathways. It also calmed excess immune cell entry and shifted those cells toward a healing mode. Blocking one pathway removed the gains.
Catalog record
| CREATOR | Xin Liu, Hui Lin, Yuting Shao, Jiaqi Shen, Yanlong Bi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |